Phase
Condition
Chest Pain
Atrial Fibrillation
Arrhythmia
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Drug-refractory paroxysmal atrial fibrillation
Exclusion
Exclusion Criteria:
Hypo or hyperthyroidism
Implantable defibrillation or pacemaker implanted
Moderate or severe mitral valve disease or mitral prosthetic valve
Ejection fraction less than 30%
Left atrial anteroposterior diameter more than 50 mm.
Previous atrial fibrillation ablation
Left atrium thrombus
Current infective disease or sepsis
Pregnant women
Current unstable angor
Acute myocardial infarction in last 3 months
Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary toany other reversible or non cardiovascular disease
Reduced expectancy of life (less than 12 months)
Patient participating in another clinical study that investigates a drug or device
Psychologically unstable patient or denies to give informed consent
Study Design
Connect with a study center
Hospital Clinic Universitari
Barcelona, 08036
SpainSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.